Page last updated: 2024-10-20

pyrazinamide and Experimental Neoplasms

pyrazinamide has been researched along with Experimental Neoplasms in 3 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
UEMURA, R1
Horsman, MR2
Chaplin, DJ2
Overgaard, J1
Trotter, MJ1
Skov, KA1

Reviews

1 review available for pyrazinamide and Experimental Neoplasms

ArticleYear
The use of blood flow modifiers to improve the treatment response of solid tumors.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1991, Volume: 20 Suppl 1

    Topics: Animals; Combined Modality Therapy; Hydralazine; Mice; Neoplasms, Experimental; Niacinamide; Pyrazin

1991

Other Studies

2 other studies available for pyrazinamide and Experimental Neoplasms

ArticleYear
BACTERIOSTATIC CHEMOTHERAPEUTIC AGENTS AND THE GROWTH OF MALIGNANT TUMOR.
    The Journal of the International College of Surgeons, 1964, Volume: 41

    Topics: Adenoma; Aminosalicylic Acid; Aminosalicylic Acids; Animals; Anti-Bacterial Agents; Antineoplastic A

1964
Modification of tumour radiation response in vivo by the benzamide analogue pyrazinamide.
    British journal of cancer, 1990, Volume: 62, Issue:4

    Topics: Animals; Cell Survival; Cells, Cultured; Hypoxia; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neopl

1990